United States High Potency Active Pharmaceutical Ingredient Market Report 2016

United States High Potency Active Pharmaceutical Ingredient Market Report 2016

1 High Potency Active Pharmaceutical Ingredient Overview

1.1 Product Overview and Scope of High Potency Active Pharmaceutical Ingredient

1.2 Classification of High Potency Active Pharmaceutical Ingredient

1.2.1 Synthetic

1.2.2 Biotech

1.2.3 Type III

1.3 Application of High Potency Active Pharmaceutical Ingredient

1.3.1 Oncology

1.3.2 Hormonal disorders

1.3.3 Glaucoma

1.3.4 Others

1.4 United States Market Size Sales (Value) and Revenue (Volume) of High Potency Active Pharmaceutical Ingredient (2011-2021)

1.4.1 United States High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2021)

1.4.2 United States High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2021)

2 United States High Potency Active Pharmaceutical Ingredient Competition by Manufacturers

2.1 United States High Potency Active Pharmaceutical Ingredient Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States High Potency Active Pharmaceutical Ingredient Revenue and Share by Manufactures (2015 and 2016)

2.3 United States High Potency Active Pharmaceutical Ingredient Average Price by Manufactures (2015 and 2016)

2.4 High Potency Active Pharmaceutical Ingredient Market Competitive Situation and Trends

2.4.1 High Potency Active Pharmaceutical Ingredient Market Concentration Rate

2.4.2 High Potency Active Pharmaceutical Ingredient Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States High Potency Active Pharmaceutical Ingredient Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 United States High Potency Active Pharmaceutical Ingredient Sales and Market Share by Type (2011-2016)

3.2 United States High Potency Active Pharmaceutical Ingredient Revenue and Market Share by Type (2011-2016)

3.3 United States High Potency Active Pharmaceutical Ingredient Price by Type (2011-2016)

3.4 United States High Potency Active Pharmaceutical Ingredient Sales Growth Rate by Type (2011-2016)

4 United States High Potency Active Pharmaceutical Ingredient Sales (Volume) by Application (2011-2016)

4.1 United States High Potency Active Pharmaceutical Ingredient Sales and Market Share by Application (2011-2016)

4.2 United States High Potency Active Pharmaceutical Ingredient Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 United States High Potency Active Pharmaceutical Ingredient Manufacturers Profiles/Analysis

5.1 Alkermes

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 High Potency Active Pharmaceutical Ingredient Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Alkermes High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Cambex

5.2.2 High Potency Active Pharmaceutical Ingredient Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Cambex High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Dr. Reddy’s Labotatories

5.3.2 High Potency Active Pharmaceutical Ingredient Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Dr. Reddy’s Labotatories High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Lonza Group

5.4.2 High Potency Active Pharmaceutical Ingredient Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Lonza Group High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Novasep

5.5.2 High Potency Active Pharmaceutical Ingredient Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Novasep High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Sandoz

5.6.2 High Potency Active Pharmaceutical Ingredient Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Sandoz High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

...

6 High Potency Active Pharmaceutical Ingredient Manufacturing Cost Analysis

6.1 High Potency Active Pharmaceutical Ingredient Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of High Potency Active Pharmaceutical Ingredient

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 High Potency Active Pharmaceutical Ingredient Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of High Potency Active Pharmaceutical Ingredient Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 United States High Potency Active Pharmaceutical Ingredient Market Forecast (2016-2021)

10.1 United States High Potency Active Pharmaceutical Ingredient Sales, Revenue Forecast (2016-2021)

10.2 United States High Potency Active Pharmaceutical Ingredient Sales Forecast by Type (2016-2021)

10.3 United States High Potency Active Pharmaceutical Ingredient Sales Forecast by Application (2016-2021)

10.4 High Potency Active Pharmaceutical Ingredient Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

Figure Picture of High Potency Active Pharmaceutical Ingredient

Table Classification of High Potency Active Pharmaceutical Ingredient

Figure United States Sales Market Share of High Potency Active Pharmaceutical Ingredient by Type in 2015

Figure Synthetic Picture

Figure Biotech Picture

Table Application of High Potency Active Pharmaceutical Ingredient

Figure United States Sales Market Share of High Potency Active Pharmaceutical Ingredient by Application in 2015

Figure Oncology Examples

Figure Hormonal disorders Examples

Figure Glaucoma Examples

Figure Others Examples

Figure United States High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2021)

Figure United States High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2021)

Table United States High Potency Active Pharmaceutical Ingredient Sales of Key Manufacturers (2015 and 2016)

Table United States High Potency Active Pharmaceutical Ingredient Sales Share by Manufacturers (2015 and 2016)

Figure 2015 High Potency Active Pharmaceutical Ingredient Sales Share by Manufacturers

Figure 2016 High Potency Active Pharmaceutical Ingredient Sales Share by Manufacturers

Table United States High Potency Active Pharmaceutical Ingredient Revenue by Manufacturers (2015 and 2016)

Table United States High Potency Active Pharmaceutical Ingredient Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States High Potency Active Pharmaceutical Ingredient Revenue Share by Manufacturers

Table 2016 United States High Potency Active Pharmaceutical Ingredient Revenue Share by Manufacturers

Table United States Market High Potency Active Pharmaceutical Ingredient Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market High Potency Active Pharmaceutical Ingredient Average Price of Key Manufacturers in 2015

Figure High Potency Active Pharmaceutical Ingredient Market Share of Top 3 Manufacturers

Figure High Potency Active Pharmaceutical Ingredient Market Share of Top 5 Manufacturers

Table United States High Potency Active Pharmaceutical Ingredient Sales by Type (2011-2016)

Table United States High Potency Active Pharmaceutical Ingredient Sales Share by Type (2011-2016)

Figure United States High Potency Active Pharmaceutical Ingredient Sales Market Share by Type in 2015

Table United States High Potency Active Pharmaceutical Ingredient Revenue and Market Share by Type (2011-2016)

Table United States High Potency Active Pharmaceutical Ingredient Revenue Share by Type (2011-2016)

Figure Revenue Market Share of High Potency Active Pharmaceutical Ingredient by Type (2011-2016)

Table United States High Potency Active Pharmaceutical Ingredient Price by Type (2011-2016)

Figure United States High Potency Active Pharmaceutical Ingredient Sales Growth Rate by Type (2011-2016)

Table United States High Potency Active Pharmaceutical Ingredient Sales by Application (2011-2016)

Table United States High Potency Active Pharmaceutical Ingredient Sales Market Share by Application (2011-2016)

Figure United States High Potency Active Pharmaceutical Ingredient Sales Market Share by Application in 2015

Table United States High Potency Active Pharmaceutical Ingredient Sales Growth Rate by Application (2011-2016)

Figure United States High Potency Active Pharmaceutical Ingredient Sales Growth Rate by Application (2011-2016)

Table Alkermes Basic Information List

Table Alkermes High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Alkermes High Potency Active Pharmaceutical Ingredient Sales Market Share (2011-2016)

Table Cambex Basic Information List

Table Cambex High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)

Table Cambex High Potency Active Pharmaceutical Ingredient Sales Market Share (2011-2016)

Table Dr. Reddy’s Labotatories Basic Information List

Table Dr. Reddy’s Labotatories High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)

Table Dr. Reddy’s Labotatories High Potency Active Pharmaceutical Ingredient Sales Market Share (2011-2016)

Table Lonza Group Basic Information List

Table Lonza Group High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)

Table Lonza Group High Potency Active Pharmaceutical Ingredient Sales Market Share (2011-2016)

Table Novasep Basic Information List

Table Novasep High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)

Table Novasep High Potency Active Pharmaceutical Ingredient Sales Market Share (2011-2016)

Table Sandoz Basic Information List

Table Sandoz High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)

Table Sandoz High Potency Active Pharmaceutical Ingredient Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of High Potency Active Pharmaceutical Ingredient

Figure Manufacturing Process Analysis of High Potency Active Pharmaceutical Ingredient

Figure High Potency Active Pharmaceutical Ingredient Industrial Chain Analysis

Table Raw Materials Sources of High Potency Active Pharmaceutical Ingredient Major Manufacturers in 2015

Table Major Buyers of High Potency Active Pharmaceutical Ingredient

Table Distributors/Traders List

Figure United States High Potency Active Pharmaceutical Ingredient Production and Growth Rate Forecast (2016-2021)

Figure United States High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate Forecast (2016-2021)

Table United States High Potency Active Pharmaceutical Ingredient Production Forecast by Type (2016-2021)

Table United States High Potency Active Pharmaceutical Ingredient Consumption Forecast by Application (2016-2021)